Overview
Robust, scalable manufacturing of novel therapeutics requires partnering with a CDMO equipped to adapt to changes in the market and knowledgeable on the latest technologies used to support cell line development.
Many offer platforms that only work for particular projects, with little or no flexibility. By utilizing an R&D team, AGC Biologics can address any cell line type, and develop customized processes and assays for each client, ensuring the cell line development is effective, stable, and scalable through commercial stages. Further, R&D scientists assess new technology to ensure that development processes are continuously being improved.
